NorthBay Healthcare joins Mayo Clinic Network

NorthBay Healthcare has become the first health care organization in Northern California to join the Mayo Clinic Care Network.

"We are pleased to welcome NorthBay to the Mayo Clinic Care Network,” said Keith Cannon, M.D., medical director, Southwest Region, Mayo Clinic Care Network. “Over the past year, we’ve taken time to get well-acquainted, and NorthBay’s commitment to meeting patients’ needs and serving the community resonates with Mayo’s deeply held values. We look forward to working together.”

The partnership will give NorthBay access to Mayo Clinic research and knowledge and promoting collaboration between physicians to provide better care and access to Mayo specialists with experience in treating rare cases of diseases.

NorthBay Healthcare physicians will have access to network services and information, Mayo’s patient education materials and archived Mayo Clinic grand rounds presentations including:

  • eConsults that allow NorthBay Healthcare physicians to collaborate electronically and directly with Mayo specialists on patient care;
  • AskMayoExpert, a database for reference at the point of care to offer the latest Mayo-vetted information on the evaluation and treatment of a variety of medical conditions;
  • Health care consulting for NorthBay physicians to learn more about Mayo’s clinical, operational and business models, including how they are designed and implemented;
  • eTumor Board conferences that invite NorthBay Healthcare physicians to present and discuss complex cancer cases with a multidisciplinary panel of Mayo specialists and other network members.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.